SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549


                                   FORM 12B-25

                           NOTIFICATION OF LATE FILING

     [ ] Form 10-K and Form 10-KSB     [ ] Form 11-K

     [ ] Form 20-F   [X] Form 10-Q and Form 10-QSB     [ ] Form N-SAR

     For the period ended September 30, 2002

     [ ] Transition Report on Form 10-K and Form 10-KSB

     [ ] Transition Report on Form 20-F

     [ ] Transition Report on Form 11-K

     [ ] Transition Report on Form 10-Q and Form 10-QSB

     [ ] Transition Report on Form N-SAR

     For the transition period ended:  N/A

     Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

     If the notification relates to a portion of filing checked above, identify
the item(s) to which the notification relates:  N/A


                                     PART I
                             REGISTRANT INFORMATION

     Full name of registrant:  NuWay Medical, Inc.

     Former name if applicable:  NuWay Energy, Inc.; Latin American Casinos,
Inc.; Repossession Auction, Inc.

     Address of principal executive office:  23461 South Pointe Drive, Suite 200

     City, state and zip code:  Laguna Hills, California 92653

                                     PART II
                             RULE 12B-25(B) AND (C)

     If the subject report could not be filed without reasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed.  (Check box if appropriate.)

               (a)  The  reasons  described  in reasonable detail in Part III of
          this  form  could  not  be  eliminated  without unreasonable effort or
          expense;

  [X]          (b)  The subject  annual  report, semi-annual report, transition
          report on Form 10-K, Form 20-F or Form N-SAR, or portion thereof, will
          be  filed  on  or  before  the  fifteenth  calendar  day following the
          prescribed  due  date;  or  the subject quarterly report or transition
          report  on  Form10-Q, Form-QSB, or portion thereof will be filed on or
          before  the  fifth calendar day following the prescribed due date; and

               (c)  The accountant's statement or other exhibit required by Rule
          12b-25(c)  has  been  attached  if  applicable.



                                    PART III
                                    NARRATIVE

     State below in reasonable detail the reasons why Form 10-K, 10-KSB, 11-K,
20-F, 10-Q, 10-QSB, N-SAR or the transition report portion thereof could not be
filed within the prescribed time period.

               The registrant is unable to file its quarterly report on Form
10-QSB for the period ending September 30, 2002, within the prescribed time
period because of a delay in providing financial information to the registrant's
auditors as a result of registrant's delay in compiling such information as a
result of changes in management.


                                     PART IV
                                OTHER INFORMATION

     (1) Name and telephone number of person to contact in regard to this
notification:

                                 Dennis Calvert
                                  949.454.9011



     (2) Have all other period reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed?  If answer is no,
identify report(s).

                                             [X] Yes [ ] No

     (3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject or portion thereof?

                                             [ ] Yes [X] No

     If so:  attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.  N/A

                               NuWay Medical, Inc.
                 ----------------------------------------------
                  (Name of Registrant as Specified in Charter)

     Has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date: November 14, 2002                  By: // Dennis Calvert
                                             -----------------
                                             Dennis Calvert, President